CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis-Reference-Cited by-同舟云学术

CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis

Published:2013-09 Issue:9 Volume:44 Page:1882-1889
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Zhang Jing,Chang Bin,Liu Jinsong

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference34 articles.

1. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation;Nagano;J Cell Biol,2004

2. CD44: structure, function, and association with the malignant process;Naor;Adv Cancer Res,1997

3. CD44 in cancer progression: adhesion, migration and growth regulation;Marhaba;J Mol Histol,2004

4. CD44 standard form expression as a predictor of progression in high risk superficial bladder tumors;Stavropoulos;Int Urol Nephrol,2001

5. Expression of a CD44 variant and VEGF-C and the implications for lymphatic metastasis and long-term prognosis of human breast cancer;Watanabe;J Exp Clin Cancer Res,2005

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies;Frontiers in Oncology;2023-06-28

2. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors;Diagnostic Pathology;2023-02-28

3. The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients;International Journal of Molecular Sciences;2023-01-25

4. Role of Hyaluronic Acid in Selected Malignant Neoplasms in Women;Biomedicines;2023-01-21

5. Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands;Diagnostics;2022-05-20